Does OLUTASIDENIB Cause Product prescribing issue? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Product prescribing issue have been filed in association with OLUTASIDENIB (REZLIDHIA). This represents 7.1% of all adverse event reports for OLUTASIDENIB.
15
Reports of Product prescribing issue with OLUTASIDENIB
7.1%
of all OLUTASIDENIB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product prescribing issue From OLUTASIDENIB?
Of the 15 reports, 5 (33.3%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLUTASIDENIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does OLUTASIDENIB Cause?
Off label use (59)
Hospitalisation (27)
Death (24)
Nausea (23)
Fatigue (21)
Product dose omission issue (19)
Constipation (14)
Transfusion (11)
Pneumonia (9)
Asthenia (7)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
Which OLUTASIDENIB Alternatives Have Lower Product prescribing issue Risk?
OLUTASIDENIB vs OMACETAXINE MEPESUCCINATE
OLUTASIDENIB vs OMADACYCLINE
OLUTASIDENIB vs OMALIZUMAB
OLUTASIDENIB vs OMAVELOXOLONE
OLUTASIDENIB vs OMBITASVIR